Modern Africa Today
SEE OTHER BRANDS

Your daily news update on Africa

Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on May 2, 2025

Aya Gold & Silver Provides Notice of First Quarter 2025 Results and Conference Call

Aya Gold & Silver Provides Notice of First Quarter 2025 Results and Conference Call

MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) plans to release its first quarter 2025 results on Tuesday, May 13, 2025 before market opens. Senior management will host a conference …

Aya Or & Argent annonce la date de diffusion de ses résultats du premier trimestre de 2025 et de sa conférence téléphonique

Aya Or & Argent annonce la date de diffusion de ses résultats du premier trimestre de 2025 et de sa conférence téléphonique

MONTRÉAL, 02 mai 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») prévoit publier ses résultats du premier trimestre de 2025 le mardi 13 mai 2025, avant l’ouverture des marchés. La haute direction tiendra …

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025

CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the …

EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025

EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025

Glasgow, Scotland – 2 May 2025. EnteroBiotix Limited (‘EnteroBiotix’), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today announced that results from its IMPuLCE Phase 1b trial evaluating EBX-102, …

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025

Tokyo, Japan and Cambridge, UK, 2 May 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2025. The full report can be found here. …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service